Cargando…
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
The retrieval of hit/lead compounds with novel scaffolds during early drug development is an important but challenging task. Various generative models have been proposed to create drug-like molecules. However, the capacity of these generative models to design wet-lab-validated and target-specific mo...
Autores principales: | Li, Yueshan, Zhang, Liting, Wang, Yifei, Zou, Jun, Yang, Ruicheng, Luo, Xinling, Wu, Chengyong, Yang, Wei, Tian, Chenyu, Xu, Haixing, Wang, Falu, Yang, Xin, Li, Linli, Yang, Shengyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653409/ https://www.ncbi.nlm.nih.gov/pubmed/36371441 http://dx.doi.org/10.1038/s41467-022-34692-w |
Ejemplares similares
-
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
por: Xia, Kaijiang, et al.
Publicado: (2020) -
A new generation M(pro) inhibitor with potent activity against SARS-CoV-2 Omicron variants
por: Huang, Chong, et al.
Publicado: (2023) -
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
por: Hou, Jue, et al.
Publicado: (2019) -
Discovery of a cooperative mode of inhibiting RIPK1 kinase
por: Meng, Huyan, et al.
Publicado: (2021) -
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
por: Zhong, Lei, et al.
Publicado: (2021)